SELLAS Life Sciences Group, Inc. Increase (Decrease) in Due to Other Related Parties, Current
SELLAS Life Sciences Group, Inc. (SLS) reported Increase (Decrease) in Due to Other Related Parties, Current of -$207.00 thousand for the 126-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToOtherRelatedPartiesCurrent · last filed 2013-08-09
- SELLAS Life Sciences Group, Inc. increase (decrease) in due to other related parties, current for the quarter ending 2013-06-30 was $0.00.
- SELLAS Life Sciences Group, Inc. increase (decrease) in due to other related parties, current for the quarter ending 2013-03-31 was $0.00.
- SELLAS Life Sciences Group, Inc. increase (decrease) in due to other related parties, current for the quarter ending 2012-12-31 was $0.00.
- SELLAS Life Sciences Group, Inc. increase (decrease) in due to other related parties, current for the quarter ending 2012-09-30 was $0.00.
| Period end | Increase (Decrease) in Due to Other Related Parties, Current 3 month | Increase (Decrease) in Due to Other Related Parties, Current 6 month | Increase (Decrease) in Due to Other Related Parties, Current 9 month | Increase (Decrease) in Due to Other Related Parties, Current 12 month | Increase (Decrease) in Due to Other Related Parties, Current 102 month | Increase (Decrease) in Due to Other Related Parties, Current 105 month | Increase (Decrease) in Due to Other Related Parties, Current 108 month | Increase (Decrease) in Due to Other Related Parties, Current 111 month | Increase (Decrease) in Due to Other Related Parties, Current 114 month | Increase (Decrease) in Due to Other Related Parties, Current 117 month | Increase (Decrease) in Due to Other Related Parties, Current 120 month | Increase (Decrease) in Due to Other Related Parties, Current 123 month | Increase (Decrease) in Due to Other Related Parties, Current 126 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-06-30 | $0.00 derived: 10-Q 126 month − 10-Q 123 month · filed 2013-08-09 | $0.00 derived: sum of 2 quarters · filed 2013-08-09 | $0.00 derived: sum of 3 quarters · filed 2013-08-09 | $0.00 derived: sum of 4 quarters · filed 2013-08-09 | -$207.00K 10-Q · filed 2013-08-09 | ||||||||
| 2013-03-31 | $0.00 derived: 10-Q 123 month − 10-K 120 month · filed 2013-05-09 | $0.00 derived: sum of 2 quarters · filed 2013-05-09 | $0.00 derived: sum of 3 quarters · filed 2013-05-09 | $0.00 derived: sum of 4 quarters · filed 2013-05-09 | -$207.00K 10-Q · filed 2013-05-09 | ||||||||
| 2012-12-31 | $0.00 derived: 10-K 120 month − 10-Q 117 month · filed 2013-03-12 | $0.00 derived: sum of 2 quarters · filed 2013-03-12 | $0.00 derived: sum of 3 quarters · filed 2013-03-12 | $0.00 derived: sum of 4 quarters · filed 2013-03-12 | -$207.00K 10-K · filed 2013-03-12 | ||||||||
| 2012-09-30 | $0.00 derived: 10-Q 117 month − 10-Q 114 month · filed 2012-11-13 | $0.00 derived: sum of 2 quarters · filed 2012-11-13 | $0.00 derived: sum of 3 quarters · filed 2012-11-13 | $0.00 derived: sum of 4 quarters · filed 2012-11-13 | -$207.00K 10-Q · filed 2012-11-13 | ||||||||
| 2012-06-30 | $0.00 derived: 10-Q 114 month − 10-Q 111 month · filed 2012-08-14 | $0.00 derived: sum of 2 quarters · filed 2012-08-14 | $0.00 derived: sum of 3 quarters · filed 2012-08-14 | $0.00 derived: sum of 4 quarters · filed 2012-08-14 | -$207.00K 10-Q · filed 2012-08-14 | ||||||||
| 2012-03-31 | $0.00 derived: 10-Q 111 month − 10-K 108 month · filed 2012-05-14 | $0.00 derived: sum of 2 quarters · filed 2012-05-14 | $0.00 derived: sum of 3 quarters · filed 2012-05-14 | -$207.00K 10-Q · filed 2012-05-14 | |||||||||
| 2011-12-31 | $0.00 derived: 10-K 108 month − 10-Q 105 month · filed 2012-03-28 | $0.00 derived: sum of 2 quarters · filed 2012-03-28 | -$207.00K 10-K · filed 2012-03-28 | ||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 105 month − 10-Q/A 102 month · filed 2011-11-14 | -$207.00K 10-Q · filed 2011-11-14 | |||||||||||
| 2011-06-30 | -$207.00K 10-Q/A · filed 2011-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |